Ariba & Mac Limited connects pharmaceutical and biotechnology R&D, clinical research, CMC and technology transfer, quality and regulatory planning, healthcare facility development, training and investor advisory. From our Saudi base, we coordinate scientific and operational workstreams with local context and international partners so clients can move from strategy to documented execution with fewer handoff gaps.
In the near future, Ariba & Mac Limited plans to establish a full-fledged International Research and Innovation Centre in Jeddah, Saudi Arabia, equipped with modern infrastructure for focused Cancer and Biotechnology Research, Development, and Technology Transfer. Our goal is to enable local commercial organizations to access high-quality R&D in the shortest possible time and at the lowest feasible cost, aligned with the broader objectives of Vision 2030.
Ariba & Mac Limited provides integrated, research and innovation based services across Pharmaceuticals, Biotechnology, Healthcare, Cosmetology and Aesthetics by combining global expertise with local insight—ensuring compliance, innovation, and trust.
Ariba & Mac Limited is a Saudi Arabia–based joint venture bringing together healthcare, pharmaceutical and research capabilities from the USA, Pakistan, UK and Türkiye. We support organizations that need scientific development, regulatory-aware execution, technology transfer, facility planning or investment support while keeping the project connected to its intended Saudi and international market requirements.
With its valuable assets like 500+ expert scientists and inventors, trained staff, and sophisticated infrastructure, Ariba & Mac Limited encourages collaborations with international companies. These activities help us track our developmental activities against the highest benchmarks.
Learn More
We support pharmaceutical companies, healthcare investors, beauty & wellness brands, and clinical institutions with strategic, scientific, and regulatory expertise — delivering compliant, market-ready outcomes.
Drug discovery, analytical testing, formulation, and biotech innovation programs.
Trial design, CRO management, site coordination, and GCP compliance.
Process optimization, validation, scale-up, and GMP manufacturing support.
eCTD submissions, SFDA/FDA/EMA compliance, and post-market support.
Audit readiness, QMS design, validation, CAPA, and compliance audits.
End-to-end project setup for pharma, hospitals, colleges and aesthetics ventures.
Clinical dermatology, hair restoration, lasers, and nutraceutical innovations.
Injectables, PRP, regenerative treatments, and anti-aging innovations.
Turnkey development of healthcare facilities with planning, equipment, compliance, and quality.
Evidence‑based assessments covering Science, Operations, Regulatory Posture, and Market Outlook.
Our tailored training programmes upskill your entire workforce with courses taught by instructors
Scholarship and training programs to support student, young professional and early career researchers.
Complex healthcare and life-sciences projects often fail at the interfaces between disciplines. We connect scientific development, regulatory planning, quality systems, vendors, facilities and implementation so clients can see dependencies earlier and make decisions with a clearer evidence trail.
Integrated Project Delivery
Support can span consultancy, research, facilities, quality and partner coordination, reducing the risk that one workstream advances without the evidence or inputs another workstream needs.
Regulatory-Aware Execution
Projects are planned with the applicable SFDA and international requirements in mind. The objective is not to promise approval, but to reduce preventable gaps, rework and disconnected documentation.
We work with pharmaceutical and biotech companies, hospitals and clinics, diagnostic laboratories, dermatology and aesthetic operators, nutraceutical and skincare brands, universities, research institutions, startups, investors and lenders. In Saudi Arabia, this can include projects linked to localization, biotechnology growth, healthcare transformation, new facilities, market entry or regulated product development.
Strategic Consultancy, Facilities and Research Services for Regulated Markets.
Product and process development, stability and analytical work, CMC/technology transfer, facility and equipment planning, QMS, validation, clinical coordination and regulatory support.
Healthcare facility and diagnostic-lab planning, workflow and equipment coordination, QMS/SOPs, commissioning, training, IT interfaces and readiness for applicable licensing or accreditation objectives.
Clinic and treatment-program support spanning device selection, SOPs, training, skincare protocols and patient-facing cosmetology or aesthetic services where those activities are within the agreed clinical scope.
Academic-commercial collaboration, research and technology-transfer programs, project screening, technical due diligence, startup advisory and investment-oriented execution planning.
Whether the assignment is R&D, clinical research, CMC, a facility project or investor diligence, we begin by defining the decision, deliverables and constraints. The project plan then connects scientific, regulatory, quality, vendor and operational activities to measurable milestones and review points.
Clarify the business or scientific objective, current evidence, target market, stakeholders, known risks, timeline expectations and the specific deliverables needed from the engagement.
Define the technical approach, partner/vendor roles, regulatory and quality requirements, documentation standards, milestones and decision gates before execution begins.
Carry out or coordinate the agreed work, review results and risks at milestones, document decisions, and prepare a clear handover for the next development, regulatory, investment or operational stage.
The engagement model is selected according to the work required. A defined technical package may suit a project scope; ongoing regulatory, quality or project-management needs may suit a retainer; larger investment or development programs may require a longer-term partnership structure. Scope, responsibilities and decision rights are agreed before work starts.
Ideal for defined deliverables and specific timelines.
For ongoing advisory and continuous support.
Strategic partnerships for long-term growth and innovation.
For current official requirements, standards and sector guidance, consult the relevant authority directly. These independent external resources are provided for reference and do not imply affiliation or replace project-specific regulatory, legal or clinical advice.
These answers explain how projects are scoped, how Saudi and international requirements are handled, and what clients can expect before a technical or commercial engagement begins.
We support pharmaceutical and biotech R&D, clinical/preclinical research, CMC and technology transfer, regulatory and quality work, healthcare facility development, training, cosmetology/aesthetic services, turnkey investor projects and technical due diligence. Scope is confirmed according to the actual project and available evidence.
Yes. Saudi requirements can be planned alongside the needs of other target markets when the project calls for it. The exact regulatory pathway, documentation and authority interactions depend on the product, service, development stage and jurisdiction.
Yes. Partner identification, technical evaluation, role definition, documentation requirements and ongoing coordination can be included where the project relies on external specialist capabilities.
Qualification is handled according to project risk and requirements. We review relevant capability, quality, documentation and accreditation or certification evidence where needed rather than assuming every partner is suitable for every project.
Send a short description of the objective, current stage, available data or documents, target market, timeline and the decision you need to make next. We use that information to define scope, assumptions, deliverables and the most appropriate engagement model before execution begins.
How Saudi Arabia is driving biotech excellence — integrating global science, innovation, and policy to deliver Vision 2030 goals.
A deep dive into how Saudi Arabia aligns with ICH, SFDA, and FDA frameworks to ensure world-class regulatory compliance in biopharma.
From R&D to manufacturing — how Saudi Arabia is transforming its life sciences ecosystem into a global hub for innovation and growth.
